Related references
Note: Only part of the references are listed.Current status of development of methylation biomarkers for in vitro diagnostic IVD applications
Olga Taryma-Lesniak et al.
CLINICAL EPIGENETICS (2020)
MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Monika E. Hegi et al.
CLINICAL CANCER RESEARCH (2019)
Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages
Martina Schmitz et al.
BMC CANCER (2018)
Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
Gunter Weiss et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer
Na Wang et al.
ARCHIVES OF MEDICAL RESEARCH (2016)
A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer
Angel Diaz-Lagares et al.
CLINICAL CANCER RESEARCH (2016)
Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2
Sujata Bhoi et al.
EPIGENETICS (2016)
Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients
Melanie Spitzwieser et al.
ONCOTARGET (2016)
Clinical Performance of an Automated Stool DNA Assay for Detection of Colorectal Neoplasia
Graham P. Lidgard et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies
Tomasz K. Wojdacz et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2010)
Primer design versus PCR bias in methylation independent PCR amplifications
Tomasz K. Wojdacz et al.
EPIGENETICS (2009)
MethyLight: a high-throughput assay to measure DNA methylation
Cindy A. Eads et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
